S62G (p.Ser62Gly) variant of KRT17 (Keratin, type I cytoskeletal 17)

S62G (p.Ser62Gly) in KRT17 (Keratin, type I cytoskeletal 17) is a missense change. Clinical records from EBI and UniProt describe it as benign. The record also includes structural context.

S62G (p.Ser62Gly) variant details